ReviewVeterinary world2024
Extended-spectrum β-lactamase-producing
Review in Veterinary world, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Multidrug-resistant Enterobacterales in commercial laying and free-range hens (Gallus gallus domesticus) under semiarid conditions of the Caatinga biome.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Article
- Characterization of antibiotic-resistant bacteria and phylogenetic analysis ofOne health (Amsterdam, Netherlands) · 2026Article
- Molecular detection of CTX-M ESBL-encoding genes inOpen veterinary journal · 2026Article
- Molecular Epidemiology of theMicroorganisms · 2026Article
- Tracking ESBL-ProducingVeterinary sciences · 2026Article
- Baicalin potentiates cefquinome against animal-origin ESBL-Frontiers in veterinary science · 2026Article
- Molecular characterization of Salmonella isolates from poultry in Egypt: Detection of virulence, ESBLs genes and antimicrobial resistance profiling.Veterinary research communications · 2025Article
- Prevalence, antimicrobial resistance, and extended-spectrum β-lactamase gene profiles ofVeterinary world · 2025Article
- Occurrence and Molecular Characterization of Extended-Spectrum Beta-Lactamase (ESBL)-ProducingAntibiotics (Basel, Switzerland) · 2025Article
- Molecular detection of CTX-M gene from ducks sold in traditional markets in Surabaya, Indonesia.Open veterinary journal · 2025Article
- Extended-Spectrum-Beta-Lactamase (ESBL)-ProducingAntibiotics (Basel, Switzerland) · 2025Article
- Dissemination and phenotypic characterization of ESBL-producingOpen veterinary journal · 2025Article
- Prevalence and Antimicrobial Resistance of ESBLMicroorganisms · 2025Article
- CTX-M-ProducingInfection and drug resistance · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extended-spectrum β-lactamases (ESBLs) are β-lactamase enzymes produced by Gram-negative bacterial pathogens that harbor the ESBL genes. In addition, most ESBL genes are plasmid-mediated and usually encode a broader spectrum of antimicrobial resistance, especially to penicillins, first-generation, second-generation, and third-generation cephalosporins, as well as monobactam, such as aztreonam.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.